Virobay, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.virobayinc.com
Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)
- First Posted Date
- 2013-09-20
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Virobay Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT01947738
- Locations
- 🇺🇸
Covance Evansville, Evansville, Indiana, United States
Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)
- First Posted Date
- 2013-07-30
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Virobay Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01911637
- Locations
- 🇺🇸
Covance Evansville, Evansville, Indiana, United States
Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing
- First Posted Date
- 2013-07-08
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Virobay Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01892891
- Locations
- 🇺🇸
Covance Evansville, Evansville, Indiana, United States
Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults
Phase 1
Completed
- Conditions
- Chronic Hepatitis C Infection
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2013-12-31
- Lead Sponsor
- Virobay Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT00557583
- Locations
- 🇺🇸
Covance Clinical Research Unit, Madison, Wisconsin, United States
© Copyright 2025. All Rights Reserved by MedPath